Proleukin Interactions
There are 564 drugs known to interact with Proleukin (aldesleukin), along with 12 disease interactions. Of the total drug interactions, 72 are major, 475 are moderate, and 17 are minor.
- View all 564 medications that may interact with Proleukin
- View Proleukin disease interactions (12)
Most frequently checked interactions
View interaction reports for Proleukin (aldesleukin) and the medicines listed below.
- Actos (pioglitazone)
- Afinitor (everolimus)
- amitriptyline
- ceftriaxone
- clarithromycin
- Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Decadron (dexamethasone)
- diflunisal
- digoxin
- Dilantin (phenytoin)
- Elavil (amitriptyline)
- Exjade (deferasirox)
- Gleevec (imatinib)
- hydroxychloroquine
- Imuran (azathioprine)
- Lipitor (atorvastatin)
- lovastatin
- MS Contin (morphine)
- Ogivri (trastuzumab)
- Paradione (paramethadione)
- pimozide
- Plavix (clopidogrel)
- Pondimin (fenfluramine)
- prednisone
- Reglan (metoclopramide)
- remdesivir
- Seldane (terfenadine)
- Sinemet (carbidopa / levodopa)
- Tegretol (carbamazepine)
- vinblastine
Proleukin disease interactions
There are 12 disease interactions with Proleukin (aldesleukin) which include:
- autoimmune diseases
- cardiovascular disease
- edema
- hepatic dysfunction
- hypotension
- myelosuppression
- neutrophil dysfunction
- organ transplant
- pulmonary dysfunction
- renal dysfunction
- seizures
- mental status changes
More about Proleukin (aldesleukin)
- Proleukin consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukins
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.